In Zheng Li's absence, only Cheng Gang went to Yanjing for the meeting in his place.
In the past two years, Yanjing has held many meetings and participated in remote video conferences.
But there are still only a few people who actually participate offline.
Especially since only one company, Kechuang Biotech, participated, it seemed like this was the first time.
In the past, Endorphins would be licensed to external patents, firstly because the production capacity of Kechuang Biotechnology could not keep up with demand.
The production process of endorphins places high demands on operators. It takes a long time to cultivate and expand production capacity.
Secondly, it was also due to the general environment at that time that the government hinted that Kechuang Biotechnology would license the endorphin patent to external parties, at least to a group of domestic pharmaceutical companies, and they would pay patent licensing fees.
Therefore, Kechuang Biotechnology simply works together to license biopharmaceutical companies around the world, and everyone can produce endorphins as long as they pay money.
It is precisely because of this operation of Kechuang Biotech that year that Amerikan has always felt that Kechuang Biotech is a target that can be fought for.
Therefore, at best, Science and Technology Biotech will be put on the watch list without any direct sanctions.
Even if Kechuang Biotech makes revolutionary progress in lithium battery technology, Amerikan will not sanction it.
Because the top companies in lithium battery production are all in East Asia, such as CATL and BYD in China, Panasonic in Neon, LG and Samsung in Kimchi country.
American has no involvement in the lithium battery production industry.
If Kechuang Biotechnology develops semiconductors or artificial intelligence, it will be sanctioned.
"Come on, Mr. Cheng, this is the first time we have met. I mainly want to talk to you about the development of Kechuang Biotechnology in the past few years and your future plans."
"Leader, Kechuang Biotechnology is currently mainly a technology research and development enterprise. Especially after the brain-computer connection technology was developed, we determined this route and operated the company through technology research and development patent authorization.
In the future, we will continue to increase investment in the field of research and development, and continue to invest in biomedicine and brain-computer connection, the two main axes of the company. "
"So what's going on with the lithium battery this time? It doesn't seem to be biomedicine."
"Leader, lithium battery technology is a project personally handled by our chairman Zheng Li at the Lion City R&D Center.
I don’t know if you know it, but Zheng Li is the founder of Kechuang Biotechnology and the main inventor of brain-computer connection and endorphins. "
"I have heard about this young talent. In fact, I also want to meet him. Unfortunately, he is still in the Lion City. However, after the previous incident, we have entrusted colleagues in the embassy to pay more attention to the safety of overseas Chinese. "
This is true. After the Kechuang Biotechnology Lion City R&D Center was invaded, the Chinese Embassy in Lion City had a lot more military attachés.
"I am very grateful to the country for its continued support to Kechuang Bio. This time the lithium battery technology also comes from the scientific research and innovation of our chairman.
Director Zheng majored in mathematics. Even after he devoted himself to research and development in the field of biomedicine, he still did not give up research in the field of mathematics.
In fact, Kechuang Biotech's brain-computer connection technology is essentially an advancement in mathematics, which denoises human brain wave signals.
Compared with other brain-computer connection manufacturers, our biggest advantage is that our algorithm is more advanced. The algorithm can accurately identify the brain wave signal by the computer after processing it.
The essence of this lithium battery technology innovation is also mathematics. Director Zheng himself is interested in the new energy industry. When he was reading the literature, he realized that the structure of lithium metal could be optimized.
So Zheng Dong combined a certain topological structure of mathematics to optimize the structure of lithium metal, and achieved the current results.
Since my own mathematics has long been returned to the teacher, I don’t remember the specific topological structure that inspired Director Zheng. "
When Cheng Gang was studying for his PhD, biocomputing was not yet popular, and their requirements for mathematics were far lower than they are now. Not to mention that Cheng Gang has been away from the front line of scientific research for so many years. Let alone topology, he has probably forgotten all about high-level mathematics in college.
"Hahaha, I understand it completely. Then I have a question. How does the cost of Kechuang Biotechnology's lithium battery technology compare with the current mainstream cathode materials? How is its safety?"
"It is safer than the current mainstream cathode materials. We have improved the stability through a unique graphene material. The cost is expected to be about 20 to 30 percent higher than the current mainstream products.
As production capacity is expanded, costs will be reduced. "
Cheng Gang's answer was beyond the other party's expectation. The acceptable range of the other party was that it was twice as expensive as the current cathode material. Even if it was twice as expensive as the current cathode material, they would increase subsidies to promote it.
“Very well, you did a great job.
China's industrial improvement depends on continuous technological innovation. In this regard, Science and Technology Innovation is worthy of being the leader of the Science and Technology Innovation Board.
In addition, this is also a rare opportunity to promote industrial progress. Are you planning to license the patent this time or build your own factory? "
"For patent authorization, we will only authorize patents for domestic enterprises in China in the early stage."
"Very good, it is a good thing that you have the intention to support the progress of China's industry. We will also support scientific and technological innovation at the government level.
In addition, if you grant patent authorization to all battery manufacturers, then I hope Kechuang Biotechnology can take the lead in promoting battery replacement standards. "
China's central bank will have a massive amount of cash in its hands in 2022, waiting to be released to offset the impact of the Federal Reserve's interest rate hikes.
Therefore, we call for investing money in new infrastructure from the beginning of the year to the end of the year. As for what is the new infrastructure? Eastern and Western computing, 5G base stations, big data centers, new energy vehicles and other fields.
It is unrealistic to use real estate to stimulate economic development, so a new model is needed to absorb the over-issued currency and transfer the over-issued currency to residents through new infrastructure.
The lithium battery developed by Kechuang Biotech this time can have a positive impact on macroeconomic policies.
The increased penetration of new energy vehicles has brought about a substantial increase in electricity consumption. UHV construction and green energy construction can be promoted with greater efforts.
The battery replacement standard, which has been unable to be pushed forward before, can also be pushed forward.
A big problem with new energy is that charging takes time. It takes five minutes to refuel and half an hour to charge.
Therefore, some people have come up with a solution, which is to replace the battery. It only takes five minutes for the new energy vehicle to go to the charging station and replace the dead battery with a charged battery.
China launched a national battery replacement standard as early as 2021.
However, due to the different battery models and standards between different manufacturers, there are also differences between the batteries of old models and the batteries of new models.
Even with the national-level battery replacement standards, battery replacement still cannot be pushed forward.
The power exchange industry is also part of the new infrastructure and can bear a large part of the over-issuance of currency.
"Okay, we will sign relevant requirements with each manufacturer and require them to use our technology to produce lithium batteries of the same standard."
Kechuang Biotechnology's promotion of this matter is a market behavior, which is equivalent to exchanging profits for compromises of various battery manufacturers.
Originally, Kechuang Biotechnology may only require battery manufacturers to pay economic benefits, but now that the state has intervened, battery manufacturers need to pay other benefits.
"Another thing is that as an excellent company, Kechuang Biotech can contact state-owned enterprises when they are short of funds. Whether it is CICC or Huaguo Investment, they are willing to help you."
...
"The website of the National Patent Office of China shows that Kechuang Biotech has applied for a patent on a technology related to lithium-ion battery cathode materials. The applicant for this patent is Zheng Li, chairman of Kechuang Biotech, and the application time is February 2023.
The patent specification states that this technology can increase the energy density of lithium metal batteries, reaching a breakthrough of 700wh/kg, and improve the stability of the battery.
Data released by Kechuang Biotech shows that the single energy density of lithium-ion batteries using its new cathode material reaches 700 wh/kg..."
As soon as the news came out, Kechuang Biotech closed the daily limit at the opening of the market the next morning, and all stocks in the Salt Lake lithium extraction sector and lithium mining sector were soaring.
On the contrary, battery manufacturers are falling.
Because the current situation is completely unclear, there is no accurate information on whether Kechuang Biotech has authorized patents or is building its own factory for production.
The outside world can only speculate that Kechuang Biotechnology will grant patents as usual, but only a few people know whether it will happen.
Battery manufacturers only fell slightly, while CATL fell sharply.
Because lithium batteries can achieve 700wh/kg, the implementation of their sodium-ion battery technology is even further away.
Moreover, the amount of A-share funds is so large, and the daily limit of Kechuang Biotech has a siphon effect on other large-cap stocks, and all the funds have been sucked away.
Both Ningde Times and Moutai are falling, but Ningde Times is falling even more fiercely.
"Kechuang Bio is indeed a Ke Chuang Bio. When it was launched, I bought it first hand and I really made a mistake. I kept it for my daughter as a gift when she grows up.
My only regret is not buying more. "
"I never thought that you, a thick-browed guy like Kechuang Biotechnology, would also engage in new energy? It turns out that the previous riots in the Salt Lake lithium extraction sector were all because of you."
"One hundred percent the news was leaked in advance, and these organizations jumped the gun."
"The technology is still on paper and is still far from being put into practice. It is still unclear whether Kechuang Biotech's cathode materials can be put into practice on a large scale."
"The capital market has reacted so strongly. It has been rising for a month since the end of January. It will definitely be implemented on a large scale, otherwise the reaction would not be so strong."
"Science and Technology Biotech is awesome. It is one of the few companies in China that truly has core technologies. Fortunately, there are these technology-based companies, so that China's stock market is not all about Maotai-flavor technology and Luzhou-flavor technology."
"Science and Technology Biotech has such great benefits every year. It is really good. You must know that Science and Technology Biotechnology will also have a brain-computer connection VR to be released this year. I feel that the current valuation is still low."
Domestic propaganda has been saying that the US stock market is a bubble, but in fact the valuations of the giant companies in the US stock market are not high.
On the contrary, the valuations of many Chinese companies are soaring to the sky.
To give a very simple example, TSMC's dynamic price-to-earnings ratio is 26.6, while the benchmark SMIC's price-to-earnings ratio is almost 47.
However, SMIC does have greater room for improvement.
Not only did the stock market respond enthusiastically, but the new cathode material developed by Kechuang Biotechnology made the industry even more excited.
